Sanofi (EPA:SAN) Stock Jumps 0.2% – Should You Buy?

Shares of Sanofi (EPA:SAN – Get Free Report) were up 0.2% during mid-day trading on Wednesday. The company traded as high as €86.25 and last traded at €85.95. Approximately 3,213,951 shares were traded during trading, an increase of 5% from the average daily volume of 3,050,000 shares. The stock had previously closed at €85.76.

Sanofi Stock Up 0.2%

The firm has a fifty day moving average price of €74.96 and a 200 day moving average price of €76.88.

About Sanofi

(Get Free Report)

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines.

Further Reading

• Five stocks we like better than Sanofi
• Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
• AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
• Powering Up the Moon: Redwire’s $40 Million NASA Award
• Can Constellation Energy’s Contracts Power a Stock Rebound?